In this context, one should keep in mind that the FAAH inhibitor URB597 and hypertension may affect cardiac and plasma oxidative stress, endocannabinoid levels and lipid metabolism in a model-dependent manner [48,49]. This evidence concerns the gene FAAH and Hypertension.